Company attributes
Other attributes
Iora Health is a healthcare company helping patients management their health and their involvement in the healthcare system that is headquartered in Boston, Massachusetts and was founded in 2011 by Christopher McKown and Rushika Fernandopulle.
On January 1, 2011 Iora Health announced raising an undisclosed of venture funding from Eight Roads Ventures.
On October 24, 2011 Iora Health announced raising $6.3 million in series A funding from investors.
On April 17, 2013 Iora Health announced raising $14 million in series B funding from Tony Hsieh (lead investor), Polaris Partners, .406 Ventures, and F-Prime Capital. The company plans on using their series B funding to expand its operations in the markets it is operating in.
On January 26, 2015 Iora Health announced raising $28 million in series C funding from Flare Capital Partners (lead investor), Polaris Partners, Khosla Ventures, GE Ventures, F-Prime Capital, and .406 Ventures. The co-founder and CEO of Iora Health, Rushika Fernandopulle, made the following statements regarding the company's series C funding round:
We’re humbled by the great interest in our Series C financing and we are honored to have such a great group of new investors join our current ones. In the last four years, Iora Health has grown from a start up with an idea of how to improve health care to serving and improving the lives of thousands of patients across the U.S.. We are excited to grow with this round to continue to deliver on our mission to restore humanity to health care.
On October 13, 2016 Iora Health announced raising $75 million in series D funding from Temasek Holdings (lead investor), Rice Management Company, Polaris Partners, Khosla Ventures, GE Ventures, Flare Capital Partners, F-Prime Capital, and .406 Ventures. Terry McGuire, a board member of Iora Health and partner of Polaris Partners, made the following comments regarding Iora Health's series D round:
Iora Health continues to unlock tremendous value through its current partnerships, with a deep pipeline of others on the way. We are showing very attractive unit economics and the ability to rapidly scale in multiple geographies. We are excited to continue to support Iora in its journey to transform health care.
On May 21, 2018 Iora Health announced raising $100 million in series E funding from Flare Capital Partners (lead investor), Temasek Holdings, Polaris Partners, Khosla Ventures, Humana, GE Ventures, Flare Capital Partners, F-Prime Capital Partners, Devonshire Investors, and .406 Ventures. Rushika Fernandopulle, Co-Founder and CEO of Iora Health, made the follwoing comments on the company's series E funding round:
Last year we doubled our number of patients, and we are on track to do the same this year. Iora's vision since our inception has been to transform health care. To have truly transformative impact, we must continue to grow and care for more patients. With the support of our investors, this new funding will allow us to deliver our high quality care to more patients in new and existing markets.
On February 10, 2020 Iora Health announced raising $126 million in series F funding from Premjilnvest (lead investor), Temasek Holdings, Polaris Partners, Khosla Ventures, Flare Capital Partners, F-Prime Capital, Devonshire Investors, Cox Enterprise, and .406 Ventures. The copmany plans on using their series F funding to grow, refine, and optimize their care model, and to improve their Medicare-certified electronic health records system.
